1,093
Views
8
CrossRef citations to date
0
Altmetric
Review Article

RNA interference technology with emphasis on delivery vehicles—prospects and limitations

, , , , &
Pages 1391-1399 | Received 25 Mar 2015, Accepted 30 May 2015, Published online: 03 Jul 2015

References

  • Aigner A. 2006. Gene silencing through RNA interference (RNAi) in vivo: Strategies based on the direct application of siRNAs. J Biotechnol. 124:12–25.
  • Akhtar S, Benter IF. 2007. Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest. 117:3623–3632.
  • Akinc A, Thomas M, Klibanov AM, Langer R. 2005. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med. 7:657–663.
  • Alexis F, Pridgen E, Molnar LK, Farokhzad OC. 2008. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 5:505–515.
  • Aoki H, Satoh M, Mitsuzuka K, Ito A, Saito S, Funato T, et al. 2004. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase. FEBS Lett. 567:203–208.
  • Bartlett DW, Davis ME. 2008. Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol Bioeng. 99:975–985.
  • Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. 2007. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A. 104:15549–15554.
  • Bernstein E, Caudy AA, Hammond SM, Hannon GJ. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 409:363–366.
  • Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 92:7297–7301.
  • Convertine AJ, Benoit DS, Duvall CL, Hoffman AS, Stayton PS. 2009. Development of a novel endosomolytic diblock copolymer for siRNA delivery. J Control Release. 133:221–229.
  • Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. 2006. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer. 107:459–466.
  • Davis ME. 2009. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm. 6:659–668.
  • Davis ME, Zuckerman JE, Choi CHJ, Seligson D, Tolcher A, Alabi CA, et al. 2010. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature. 464: 1067–1070.
  • Druker BJ, Guilhot F, O'brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. 2006. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 355: 2408–2417.
  • Duan Y, Yang C, Zhang Z, Liu J, Zheng J, Kong D. 2010. Poly(ethylene glycol)-grafted polyethylenimine modified with G250 monoclonal antibody for tumor gene therapy. Hum Gene Ther. 21:191–198.
  • Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494–498.
  • Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, Scarpa M. 1997. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther. 4:1100–1106.
  • Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
  • Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. 2003. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 24:1121–1131.
  • Gao H, Shi W, Freund LB. 2005. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 102:9469–9474.
  • Gaumet M, Vargas A, Gurny R, Delie F. 2008. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 69:1–9.
  • Godbey WT, Wu KK, Hirasaki GJ, Mikos AG. 1999. Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther. 6:1380–1388.
  • Godbey WT, Wu KK, Mikos AG. 2001. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials. 22:471–480.
  • Grayson AC, Doody AM, Putnam D. 2006. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res. 23:1868–1876.
  • Grzelinski M, Urban-Klein B, Martens T, Lamszus K, Bakowsky U, Hobel S, et al. 2006. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther. 17:751–766.
  • Hammond SM, Bernstein E, Beach D, Hannon GJ. 2000. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 404:293–296.
  • Han SE, Kang H, Shim GY, Kim SJ, Choi HG, Kim J, et al. 2009. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides. J Drug Target. 17:123–132.
  • Heidel JD, Yu Z, Liu JY-C, Rele SM, Liang Y, Zeidan RK, et al. 2007. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci U S A. 104:5715–5721.
  • Höbel S, Koburger I, John M, Czubayko F, Hadwiger P, Vornlocher HP, Aigner A. 2010. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J Gene Med. 12:287–300.
  • Hobel S, Loos A, Appelhans D, Schwarz S, Seidel J, Voit B, Aigner A. 2011. Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes. J Control Release. 149:146–158.
  • Hoon Jeong J, Christensen LV, Yockman JW, Zhong Z, Engbersen JF, Jong Kim W, et al. 2007. Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials. 28:1912–1917.
  • Howard KA, Rahbek UL, Liu XD, Damgaard CK, Glud SZ, Andersen MO, et al. 2006. RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system. Mol Ther. 14:476–484.
  • Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME, Triche TJ. 2005. Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma. Cancer Res. 65: 8984–8992.
  • Jevprasesphant R, Penny J, Jalal R, Attwood D, Mckeown NB, D'emanuele A. 2003. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm. 252:263–266.
  • Ji AM, Su D, Che O, Li WS, Sun L, Zhang ZY, et al. 2009. Functional gene silencing mediated by chitosan/siRNA nanocomplexes. Nanotechnology. 20:405103.
  • Jiang G, Park K, Kim J, Kim KS, Oh EJ, Kang H, et al. 2008. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers. 89:635–642.
  • Judge AD, Bola G, Lee AC, Maclachlan I. 2006. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther. 13:494–505.
  • Katas H, Alpar HO. 2006. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 115:216–225.
  • Kim HJ, Ishii A, Miyata K, Lee Y, Wu S, Oba M, et al. 2010. Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown. J Control Release. 145:141–148.
  • Lee DW, Yun KS, Ban HS, Choe W, Lee SK, Lee KY. 2009. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. J Control Release. 139:146–152.
  • Lee H, Mok H, Lee S, Oh YK, Park TG. 2007. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release. 119:245–252.
  • Lee SH, Choi SH, Kim SH, Park TG. 2008. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: Swelling induced physical disruption of endosome by cold shock. J Control Release. 125:25–32.
  • Leung RK, Whittaker PA. 2005. RNA interference: From gene silencing to gene-specific therapeutics. Pharmacol Ther. 107: 222–239.
  • Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, et al. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 305:1437–1441.
  • Malhotra M, Kulamarva A, Sebak S, Paul A, Bhathena J, Mirzaei M, Prakash S. 2009. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells. Drug Dev Ind Pharm. 35:719–726.
  • Malhotra M, Lane C, Tomaro-Duchesneau C, Saha S, Prakash S. 2011. A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis. Int J Nanomedicine. 6:485–494.
  • Malhotra M, Tomaro-Duchesneau C, Prakash S. 2013a. Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials. 34:1270–1280.
  • Malhotra M, Tomaro-Duchesneau C, Saha S, Kahouli I, Prakash S. 2013b. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. Int J Nanomedicine. 8:2041–2052.
  • Malhotra M, Tomaro-Duchesneau C, Saha S, Prakash S. 2013c. Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer. Int J Biomater. 2013:252531.
  • Mao CQ, Du JZ, Sun TM, Yao YD, Zhang PZ, Song EW, Wang J. 2011. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials. 32:3124–3133.
  • Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R, et al. 2006. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotech. 24:559–565.
  • Martinez J, Tuschl T. 2004. RISC is a 5′ phosphomonoester-producing RNA endonuclease. Genes Dev. 18:975–980.
  • Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, Oba M, et al. 2009. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules. 10:119–127.
  • Moschos SA, Jones SW, Perry MM, Williams AE, Erjefalt JS, Turner JJ, et al. 2007. Lung delivery studies using siRNA conjugated to TAT(48–60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem. 18:1450–1459.
  • Muratovska A, Eccles MR. 2004. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 558:63–68.
  • Neu M, Fischer D, Kissel T. 2005. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med. 7:992–1009.
  • Nimesh S, Chandra R. 2009. Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system. Eur J Pharm Biopharm. 73:43–49.
  • Nykanen A, Haley B, Zamore PD. 2001. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell. 107:309–321.
  • Panyam J, Labhasetwar V. 2003. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res. 20:212–220.
  • Patnaik S, Aggarwal A, Nimesh S, Goel A, Ganguli M, Saini N, et al. 2006. PEI-alginate nanocomposites as efficient in vitro gene transfection agents. J Control Release. 114:398–409.
  • Pille JY, Li H, Blot E, Bertrand JR, Pritchard LL, Opolon P, et al. 2006. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum Gene Ther. 17: 1019–1026.
  • Plank C, Mechtler K, Szoka FC, Jr, Wagner E. 1996. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther. 7:1437–1446.
  • Pun SH, Bellocq NC, Liu A, Jensen G, Machemer T, Quijano E, et al. 2004. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug Chem. 15:831–840.
  • Rinaudo M. 2006. Chitin and chitosan: Properties and applications. Prog Polym Sci. 31:603–632.
  • Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, et al. 2004. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32:e149.
  • Seow Y, Wood MJ. 2009. Biological gene delivery vehicles: beyond viral vectors. Mol Ther. 17:767–777.
  • Shim MS, Kwon YJ. 2009. Acid-Responsive Linear Polyethylenimine for Efficient, Specific, and Biocompatible siRNA Delivery. Bioconjug Chem. 20:488–499.
  • Sioud M. 2006. Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses. Eur J Immunol. 36:1222–1230.
  • Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, et al. 2007. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet. 369:29–36.
  • Takemoto H, Ishii A, Miyata K, Nakanishi M, Oba M, Ishii T, et al. 2010. Polyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system. Biomaterials. 31:8097–8105.
  • Templeton NS, Lasic DD. 1999. New directions in liposome gene delivery. Mol Biotechnol. 11:175–180.
  • Thomas M, Klibanov AM. 2002. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A. 99:14640–14645.
  • Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM. 2005. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci U S A. 102:5679–5684.
  • Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. 2005. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12:461–466.
  • Vader P, Van Der Aa LJ, Engbersen JF, Storm G, Schiffelers RM. 2011. Disulfide-Based Poly(amido amine)s for siRNA Delivery: Effects of Structure on siRNA Complexation, Cellular Uptake, Gene Silencing and Toxicity. Pharm Res. 28:1013–1022.
  • Van Vlerken LE, Vyas TK, Amiji MM. 2007. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res. 24:1405–1414.
  • Varkouhi AK, Lammers T, Schiffelers RM, Van Steenbergen MJ, Hennink WE, Storm G. 2011. Gene silencing activity of siRNA polyplexes based on biodegradable polymers. Eur J Pharm Biopharm. 77:450–457.
  • Wightman L, Kircheis R, Rossler V, Carotta S, Ruzicka R, Kursa M, Wagner E. 2001. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med. 3:362–372.
  • Xu D, Mccarty D, Fernandes A, Fisher M, Samulski RJ, Juliano RL. 2005. Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector. Mol Ther. 11:523–530.
  • Zaiss AK, Muruve DA. 2005. Immune responses to adeno-associated virus vectors. Curr Gene Ther. 5:323–331.
  • Zhang K, Fang H, Wang Z, Li Z, Taylor JS, Wooley KL. 2010. Structure-activity relationships of cationic shell-crosslinked knedel-like nanoparticles: shell composition and transfection efficiency/cytotoxicity. Biomaterials. 31:1805–1813.
  • Zhang K, Fang H, Wang Z, Taylor JS, Wooley KL. 2009. Cationic shell-crosslinked knedel-like nanoparticles for highly efficient gene and oligonucleotide transfection of mammalian cells. Biomaterials. 30:968–977.
  • Zhang S, Zhao B, Jiang H, Wang B, Ma B. 2007. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release. 123:1–10.
  • Zhang ZY, Smith BD. 2000. High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. Bioconjug Chem. 11:805–814.
  • Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN, et al. 2006. RNAi-mediated gene silencing in non-human primates. Nature. 441:111–114.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.